174 related articles for article (PubMed ID: 30022812)
1. Effect of green tea catechins on the pharmacokinetics of digoxin in humans.
Kim TE; Shin KH; Park JE; Kim MG; Yun YM; Choi DH; Kwon KJ; Lee J
Drug Des Devel Ther; 2018; 12():2139-2147. PubMed ID: 30022812
[TBL] [Abstract][Full Text] [Related]
2. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers.
Kim TE; Ha N; Kim Y; Kim H; Lee JW; Jeon JY; Kim MG
Drug Des Devel Ther; 2017; 11():1409-1416. PubMed ID: 28533679
[TBL] [Abstract][Full Text] [Related]
3. Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers.
Song IH; Ilic K; Murphy J; Lasseter K; Martin P
J Clin Pharmacol; 2020 Jan; 60(1):96-106. PubMed ID: 31385617
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers.
Teng R; Butler K
Eur J Clin Pharmacol; 2013 Oct; 69(10):1801-8. PubMed ID: 23748750
[TBL] [Abstract][Full Text] [Related]
5. Effect of enzalutamide on PK of P-gp and BCRP substrates in cancer patients: CYP450 induction may not always predict overall effect on transporters.
Poondru S; Ghicavii V; Khosravan R; Manchandani P; Heo N; Moy S; Wojtkowski T; Patton M; Haas GP
Clin Transl Sci; 2022 May; 15(5):1131-1142. PubMed ID: 35118821
[TBL] [Abstract][Full Text] [Related]
6. Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P-glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers.
Wang X; Zhang ZY; Arora S; Hughes L; Wang J; Powers D; Christensen J; Lu S; Kansra V
J Clin Pharmacol; 2018 Feb; 58(2):202-211. PubMed ID: 28906558
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P-Glycoprotein Substrate Digoxin in Healthy Volunteers.
Scheuenpflug J; Kropeit D; Erb-Zohar K; Theis JGW; Stobernack HP; McCormick D; Zimmermann H; Rübsamen-Schaeff H
Clin Pharmacol Drug Dev; 2022 Jan; 11(1):6-15. PubMed ID: 34812580
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of green tea beverage containing cyclodextrins and high concentration catechins with P-glycoprotein substrates in LLC-GA5-COL150 cells in vitro and in the small intestine of rats in vivo.
Oda K; Murakami T
J Pharm Pharmacol; 2017 Dec; 69(12):1736-1744. PubMed ID: 28980319
[TBL] [Abstract][Full Text] [Related]
9. Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients.
Kurzawski M; Bartnicka L; Florczak M; Górnik W; Droździk M
Pharmacol Rep; 2007; 59(1):107-11. PubMed ID: 17377214
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
11. Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin.
Gouin-Thibault I; Delavenne X; Blanchard A; Siguret V; Salem JE; Narjoz C; Gaussem P; Beaune P; Funck-Brentano C; Azizi M; Mismetti P; Loriot MA
J Thromb Haemost; 2017 Feb; 15(2):273-283. PubMed ID: 27893182
[TBL] [Abstract][Full Text] [Related]
12. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.
Xu P; Jiang ZP; Zhang BK; Tu JY; Li HD
Pharmacology; 2008; 82(3):221-7. PubMed ID: 18810246
[TBL] [Abstract][Full Text] [Related]
13. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
Schmitt C; Kaeser B; Riek M; Bech N; Kreuzer C
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):192-9. PubMed ID: 20197013
[TBL] [Abstract][Full Text] [Related]
14. Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects.
Wu LX; Wen CJ; Li Y; Zhang X; Shao YY; Yang Z; Zhou HH
Br J Clin Pharmacol; 2015 Nov; 80(5):1109-21. PubMed ID: 25940551
[TBL] [Abstract][Full Text] [Related]
15. Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes.
Penzak SR; Shen JM; Alfaro RM; Remaley AT; Natarajan V; Falloon J
Ther Drug Monit; 2004 Jun; 26(3):322-30. PubMed ID: 15167636
[TBL] [Abstract][Full Text] [Related]
16. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
Zhang H; Yao M; Morrison RA; Chong S
Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of in vivo P-glycoprotein and cytochrome P450 3A activities.
Kirby B; Kharasch ED; Thummel KT; Narang VS; Hoffer CJ; Unadkat JD
J Clin Pharmacol; 2006 Nov; 46(11):1313-9. PubMed ID: 17050796
[TBL] [Abstract][Full Text] [Related]
18. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
[TBL] [Abstract][Full Text] [Related]
19. Effects of Green Tea Extract on Atorvastatin Pharmacokinetics in Healthy Volunteers.
Abdelkawy KS; Abdelaziz RM; Abdelmageed AM; Donia AM; El-Khodary NM
Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):351-360. PubMed ID: 31997084
[TBL] [Abstract][Full Text] [Related]
20. Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin.
Kadokura T; Groenendaal D; Heeringa M; Mol R; Verheggen F; Garcia-Hernandez A; Onkels H
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):1-9. PubMed ID: 23754514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
